https://stock.noler.com/us/stock/cincor-pharma-inc https://stock.noler.com/us/stock/cincor-pharma-inc/13f-holdings-corporate-securities https://stock.noler.com/us/stock/cincor-pharma-inc/accounts-payable https://stock.noler.com/us/stock/cincor-pharma-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/cincor-pharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/cincor-pharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/cincor-pharma-inc/amended-reports https://stock.noler.com/us/stock/cincor-pharma-inc/aoci https://stock.noler.com/us/stock/cincor-pharma-inc/area-of-real-estate-property https://stock.noler.com/us/stock/cincor-pharma-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/cincor-pharma-inc/assets-noncurrent https://stock.noler.com/us/stock/cincor-pharma-inc/auditor https://stock.noler.com/us/stock/cincor-pharma-inc/authorized-dilution https://stock.noler.com/us/stock/cincor-pharma-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/cincor-pharma-inc/basic-shares https://stock.noler.com/us/stock/cincor-pharma-inc/beta https://stock.noler.com/us/stock/cincor-pharma-inc/borrowing-debt https://stock.noler.com/us/stock/cincor-pharma-inc/buybacks-repurchase-programs https://stock.noler.com/us/stock/cincor-pharma-inc/capital-expenditures https://stock.noler.com/us/stock/cincor-pharma-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/cincor-pharma-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/cincor-pharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/cincor-pharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/cincor-pharma-inc/cash-and-securities https://stock.noler.com/us/stock/cincor-pharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/cincor-pharma-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/cincor-pharma-inc/clinical-trials https://stock.noler.com/us/stock/cincor-pharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cincor-pharma-inc/common-stock-value https://stock.noler.com/us/stock/cincor-pharma-inc/comprehensive-income https://stock.noler.com/us/stock/cincor-pharma-inc/congressional-trades https://stock.noler.com/us/stock/cincor-pharma-inc/convertible-securities-outstanding https://stock.noler.com/us/stock/cincor-pharma-inc/convertible-securities-retired https://stock.noler.com/us/stock/cincor-pharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/cincor-pharma-inc/current-assets https://stock.noler.com/us/stock/cincor-pharma-inc/current-liabilities https://stock.noler.com/us/stock/cincor-pharma-inc/customer-breakdown https://stock.noler.com/us/stock/cincor-pharma-inc/debt-and-obligation-disclosures https://stock.noler.com/us/stock/cincor-pharma-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/cincor-pharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/cincor-pharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/cincor-pharma-inc/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/cincor-pharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/cincor-pharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cincor-pharma-inc/defined-contribution-plan-administrative-expenses https://stock.noler.com/us/stock/cincor-pharma-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/cincor-pharma-inc/depreciation https://stock.noler.com/us/stock/cincor-pharma-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/cincor-pharma-inc/diluted-shares https://stock.noler.com/us/stock/cincor-pharma-inc/dividend-safety https://stock.noler.com/us/stock/cincor-pharma-inc/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/cincor-pharma-inc/earnings-and-revenue-growth https://stock.noler.com/us/stock/cincor-pharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/cincor-pharma-inc/ebitda https://stock.noler.com/us/stock/cincor-pharma-inc/effective-tax-rate https://stock.noler.com/us/stock/cincor-pharma-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/cincor-pharma-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/cincor-pharma-inc/eps https://stock.noler.com/us/stock/cincor-pharma-inc/eps-basic https://stock.noler.com/us/stock/cincor-pharma-inc/executive-pay-measures https://stock.noler.com/us/stock/cincor-pharma-inc/executive-pay-other https://stock.noler.com/us/stock/cincor-pharma-inc/executive-pay-pvp https://stock.noler.com/us/stock/cincor-pharma-inc/executive-pay-trading-arrangements https://stock.noler.com/us/stock/cincor-pharma-inc/executive-salary-before-2006 https://stock.noler.com/us/stock/cincor-pharma-inc/executive-salary-board https://stock.noler.com/us/stock/cincor-pharma-inc/executive-salary-equity-awards https://stock.noler.com/us/stock/cincor-pharma-inc/executive-salary-officers https://stock.noler.com/us/stock/cincor-pharma-inc/executive-salary-other-compensation https://stock.noler.com/us/stock/cincor-pharma-inc/executive-salary-other-mentions https://stock.noler.com/us/stock/cincor-pharma-inc/executive-salary-pay-ratio https://stock.noler.com/us/stock/cincor-pharma-inc/executive-salary-relatives https://stock.noler.com/us/stock/cincor-pharma-inc/fails-to-deliver https://stock.noler.com/us/stock/cincor-pharma-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/cincor-pharma-inc/financing-cash-flow https://stock.noler.com/us/stock/cincor-pharma-inc/form-d-stocks https://stock.noler.com/us/stock/cincor-pharma-inc/free-cash-flow https://stock.noler.com/us/stock/cincor-pharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/cincor-pharma-inc/gross-margin https://stock.noler.com/us/stock/cincor-pharma-inc/holders-breakdown https://stock.noler.com/us/stock/cincor-pharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/cincor-pharma-inc/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/cincor-pharma-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/cincor-pharma-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/cincor-pharma-inc/insider-holders https://stock.noler.com/us/stock/cincor-pharma-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/cincor-pharma-inc/insider-transactions-other https://stock.noler.com/us/stock/cincor-pharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/cincor-pharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/cincor-pharma-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/cincor-pharma-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/cincor-pharma-inc/insider-transactions-warrants https://stock.noler.com/us/stock/cincor-pharma-inc/institutional-holders https://stock.noler.com/us/stock/cincor-pharma-inc/interest-income-other https://stock.noler.com/us/stock/cincor-pharma-inc/investing-cash-flow https://stock.noler.com/us/stock/cincor-pharma-inc/iran-activity-notices https://stock.noler.com/us/stock/cincor-pharma-inc/late-filing-notices https://stock.noler.com/us/stock/cincor-pharma-inc/lawsuits-defendant https://stock.noler.com/us/stock/cincor-pharma-inc/lawsuits-plaintiff https://stock.noler.com/us/stock/cincor-pharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/cincor-pharma-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/cincor-pharma-inc/major-holders https://stock.noler.com/us/stock/cincor-pharma-inc/marketable-securities https://stock.noler.com/us/stock/cincor-pharma-inc/material-contracts https://stock.noler.com/us/stock/cincor-pharma-inc/mentioned-by-other https://stock.noler.com/us/stock/cincor-pharma-inc/mutual-fund-holders https://stock.noler.com/us/stock/cincor-pharma-inc/net-change-in-cash https://stock.noler.com/us/stock/cincor-pharma-inc/net-income https://stock.noler.com/us/stock/cincor-pharma-inc/news https://stock.noler.com/us/stock/cincor-pharma-inc/obligation-breakdown https://stock.noler.com/us/stock/cincor-pharma-inc/oci-before-tax https://stock.noler.com/us/stock/cincor-pharma-inc/oci-net-of-tax https://stock.noler.com/us/stock/cincor-pharma-inc/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/cincor-pharma-inc/operating-cash-flow https://stock.noler.com/us/stock/cincor-pharma-inc/operating-expenses https://stock.noler.com/us/stock/cincor-pharma-inc/operating-income https://stock.noler.com/us/stock/cincor-pharma-inc/operating-margin https://stock.noler.com/us/stock/cincor-pharma-inc/other https://stock.noler.com/us/stock/cincor-pharma-inc/other-income https://stock.noler.com/us/stock/cincor-pharma-inc/outstanding-bonds https://stock.noler.com/us/stock/cincor-pharma-inc/outstanding-bonds-foreign https://stock.noler.com/us/stock/cincor-pharma-inc/outstanding-bonds-matured https://stock.noler.com/us/stock/cincor-pharma-inc/outstanding-bonds-matured-foreign https://stock.noler.com/us/stock/cincor-pharma-inc/outstanding-bonds-matured-unclassified https://stock.noler.com/us/stock/cincor-pharma-inc/outstanding-bonds-unclassified https://stock.noler.com/us/stock/cincor-pharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/cincor-pharma-inc/patents https://stock.noler.com/us/stock/cincor-pharma-inc/patents-active https://stock.noler.com/us/stock/cincor-pharma-inc/patents-expired https://stock.noler.com/us/stock/cincor-pharma-inc/patents-pending https://stock.noler.com/us/stock/cincor-pharma-inc/patents-rejected https://stock.noler.com/us/stock/cincor-pharma-inc/payables-and-obligations https://stock.noler.com/us/stock/cincor-pharma-inc/payments-for-rent https://stock.noler.com/us/stock/cincor-pharma-inc/payments-for-repurchase-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/cincor-pharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/cincor-pharma-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/cincor-pharma-inc/pb-ratio https://stock.noler.com/us/stock/cincor-pharma-inc/pe-ratio https://stock.noler.com/us/stock/cincor-pharma-inc/preferred-shares https://stock.noler.com/us/stock/cincor-pharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/cincor-pharma-inc/preferred-stock-convertible-conversion-ratio https://stock.noler.com/us/stock/cincor-pharma-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/cincor-pharma-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/cincor-pharma-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/cincor-pharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/cincor-pharma-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/cincor-pharma-inc/profit-loss https://stock.noler.com/us/stock/cincor-pharma-inc/property-plant-equipment https://stock.noler.com/us/stock/cincor-pharma-inc/ps-ratio https://stock.noler.com/us/stock/cincor-pharma-inc/public-float https://stock.noler.com/us/stock/cincor-pharma-inc/quick-ratio https://stock.noler.com/us/stock/cincor-pharma-inc/reddit https://stock.noler.com/us/stock/cincor-pharma-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/cincor-pharma-inc/research-and-development https://stock.noler.com/us/stock/cincor-pharma-inc/retained-earnings https://stock.noler.com/us/stock/cincor-pharma-inc/sec-comment-letters https://stock.noler.com/us/stock/cincor-pharma-inc/sec-enforcement-actions https://stock.noler.com/us/stock/cincor-pharma-inc/sec-filings https://stock.noler.com/us/stock/cincor-pharma-inc/share-buybacks https://stock.noler.com/us/stock/cincor-pharma-inc/shareholder-equity https://stock.noler.com/us/stock/cincor-pharma-inc/shareholders-equity https://stock.noler.com/us/stock/cincor-pharma-inc/shares-authorized https://stock.noler.com/us/stock/cincor-pharma-inc/shares-issued https://stock.noler.com/us/stock/cincor-pharma-inc/shares-outstanding-analysis https://stock.noler.com/us/stock/cincor-pharma-inc/short-interest https://stock.noler.com/us/stock/cincor-pharma-inc/short-sale-volume https://stock.noler.com/us/stock/cincor-pharma-inc/spending-and-interest-coverage https://stock.noler.com/us/stock/cincor-pharma-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/cincor-pharma-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/cincor-pharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/cincor-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/cincor-pharma-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/cincor-pharma-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/cincor-pharma-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/cincor-pharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/cincor-pharma-inc/stock-based-compensation https://stock.noler.com/us/stock/cincor-pharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/cincor-pharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/cincor-pharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/cincor-pharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/cincor-pharma-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/cincor-pharma-inc/subsidiaries https://stock.noler.com/us/stock/cincor-pharma-inc/supplier-breakdown https://stock.noler.com/us/stock/cincor-pharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/cincor-pharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cincor-pharma-inc/tax-rate-reconciliation-disposition-of-assets https://stock.noler.com/us/stock/cincor-pharma-inc/tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/cincor-pharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/cincor-pharma-inc/total-assets https://stock.noler.com/us/stock/cincor-pharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/cincor-pharma-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/cincor-pharma-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/cincor-pharma-inc/voting-outcome https://stock.noler.com/us/stock/cincor-pharma-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/cincor-pharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/cincor-pharma-inc/youtube